Below is Validea's guru fundamental report for ASSERTIO HOLDINGS INC (ASRT). Of the 22 guru strategies we follow, ASRT rates highest using our Acquirer's Multiple Investor model based on the published ...

Here is how Assertio (ASRT) and Aura Biosciences, Inc. (AURA) have performed compared to their sector so far this year.

In Q1 FY2023, Assertio achieved significant progress in executing the new strategy brought on board by CEO Dan Peisert. The market expects ASRT's EPS to decline nearly 82% YoY in FY2023, but then ...

$ASRT insiders have traded $ASRT stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales. Here’s a ...

Shares of Assertio (NASDAQ:ASRT) closed 8% higher Monday after the company refuted allegations leveled by activist investor Buxton Helmsley over its accounting practices and approval of its drug ...

Shares of Assertio (ASRT) have gained 28.9% over the past four weeks to close the last trading session at $11.78, but there could still be a solid upside left in the stock if short-term price targets ...

Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...